Categories
Press Release

Genomics Market Expanding with Technological Drive of Pharmaceutical Companies

Genomics Market is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, The Global Genomics Market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026. In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026.

The use of genomics is expanding in the medical industry, which is creating growth opportunities for the Global Genomics Market. Fortune Business Insights in a new report, titled “Genomics: Global Market Analysis, Insights and Forecast, 2019-2026” offers valuable insights into the factors enabling growth in the market.

Segmentation

By Product Type

  • Reagents
  • Kits
  • Enzymes
  • Others

By Technology

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • MicroRNA Modification
  • Large Non-coding RNA
  • Chromatin Structures
  • Others

By Application

  • Pharmaceutical
  • Diagnostics

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Key questions answered in the Genomics Market report:

  • What will the market growth rate of Genomics market in 2026?
  • What are the key factors driving the Global Genomics market?
  • What are sales, revenue, and price analysis of top manufacturers of Genomics market?
  • Who are the distributors, traders and dealers of Genomics market?

Veritas Genetics Launched myGenome to Offer Personalized Services to its Customers

General Electric Company, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Agilent Technologies, Inc., IntegraGen, QIAGEN, BGI, F. Hoffmann-La Roche Ltd, Danaher, and Illumina, Inc. are some of the leading players in the global genomics market. Among these, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., and Illumina, Inc. are projected to dominate the global market. Strong geographical presence and robust portfolio are factors responsible for their prominent position in the market. Several companies are entering into strategic alliances to better their market position and increase revenue. Bristol Myers Squibb collaborated with Foundation Medicine in March 2017. This collaboration will help the former company to leverage the latter’s molecular information and genomic profiling solutions. Furthermore, it will help Bristol Myers to identify biomarkers such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB) in cancer patients. Another company called 10X Genomics acquired an epigenomics-based startup called Epinomics in August 2018. This acquisition will help the company strengthen its market position.

Some major points from Table of Content:

  1. Introduction

1.1.ResearchScope

1.2.MarketSegmentation

1.3.ResearchMethodology

1.4.Definitionsand Assumptions

2.Executive Summary

3.Market Dynamics

3.1.MarketDrivers

3.2.MarketRestraints

3.3.MarketOpportunities

3.4 MarketTrends

4.Key Insights

4.1GenomicsResearch Spending – For Key Countries, 2018

4.2RegulatoryScenario – For Key Countries

4.3Overview ofGenomics Service Provider

4.4New ProductLaunch

4.5Start-upswith their Funding Overview

4.5Key IndustryDevelopments – Mergers, Acquisitions and Partnerships

5.Global Genomics Market Analysis,Insights and Forecast, 2015-2026

5.1.KeyFindings / Summary

5.2.MarketAnalysis, Insights and Forecast – By Type

5.2.1Product

5.2.1.1Instruments& Software

5.2.1.2Consumables

5.2.2Services

5.3.MarketAnalysis, Insights and Forecast – By Technology

5.3.1PolymeraseChain Reaction (PCR)

5.3.2Next-generationSequencing (NGS)

5.3.3Microarray

5.3.4SangerSequencing

5.3.5Others

5.4.MarketAnalysis, Insights and Forecast – By Application

5.4.1Diagnostics

5.4.2Research

5.4.3Others

5.5.MarketAnalysis, Insights and Forecast – By End User

5.5.1ResearchInstitutes

5.5.2HealthcareFacilities & Diagnostic Centers

5.5.3Pharmaceutical& Biotechnological Companies

5.5.4ContractResearch Organization (CROs)

5.6.MarketAnalysis, Insights and Forecast – By Region

5.6.1NorthAmerica

5.6.2Europe

5.6.3AsiaPacific

5.6.4LatinAmerica

5.6.5MiddleEast & Africa

Secondary Research Is Conducted To Derive The Following Information

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  • Market & technological trends, new product developments, product pipeline.

More Trending Topics From Fortune Business [email protected]

Surgical Sutures Market Size, Share, Growth | Industry Outlook 2025

Defibrillator Market Size Growth & Industry Dynamics 2026

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Categories
Press Release

Genomics Market Is Expected to Grasp US$ 62,614.6 Mn by 2026, at a CAGR Of 18.7%

The use of genomics is expanding in the medical industry, which is creating growth opportunities for the Global Genomics Market. Fortune Business Insights in a new report, titled “Genomics: Global Market Analysis, Insights and Forecast, 2019-2026” offers valuable insights into the factors enabling growth in the market.

Genomics Market is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, The Global Industry is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026. In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Some major points from Table of Content:

  1. Introduction

1.1.ResearchScope

1.2.MarketSegmentation

1.3.ResearchMethodology

1.4.Definitionsand Assumptions

2.Executive Summary

3.Market Dynamics

3.1.MarketDrivers

3.2.MarketRestraints

3.3.MarketOpportunities

3.4 MarketTrends

4.Key Insights

4.1GenomicsResearch Spending – For Key Countries, 2018

4.2RegulatoryScenario – For Key Countries

4.3Overview ofGenomics Service Provider

4.4New ProductLaunch

4.5Start-upswith their Funding Overview

4.5Key IndustryDevelopments – Mergers, Acquisitions and Partnerships

5.Global Genomics Industry Analysis,Insights and Forecast, 2015-2026

5.1.KeyFindings / Summary

5.2.MarketAnalysis, Insights and Forecast – By Type

5.2.1Product

5.2.1.1Instruments& Software

5.2.1.2Consumables

5.2.2Services

5.3.MarketAnalysis, Insights and Forecast – By Technology

5.3.1PolymeraseChain Reaction (PCR)

5.3.2Next-generationSequencing (NGS)

5.3.3Microarray

5.3.4SangerSequencing

5.3.5Others

5.4.MarketAnalysis, Insights and Forecast – By Application

5.4.1Diagnostics

5.4.2Research

5.4.3Others

5.5.MarketAnalysis, Insights and Forecast – By End User

5.5.1ResearchInstitutes

5.5.2HealthcareFacilities & Diagnostic Centers

5.5.3Pharmaceutical& Biotechnological Companies

5.5.4ContractResearch Organization (CROs)

5.6.MarketAnalysis, Insights and Forecast – By Region

5.6.1NorthAmerica

5.6.2Europe

5.6.3AsiaPacific

5.6.4LatinAmerica

5.6.5MiddleEast & Africa

A Myriad of R&D Activities Has Spurred Growth Prospects for Market

“Several services and start-up companies are paving their way into genomics industry by offering services which include ancestry services, direct-to-customer genomic services, among others,” stated a lead analyst at Fortune Business Insights. “Rising support from governments regarding research and funding is expected to contribute to the growth of the market,” he added. Several genomic institutes are supporting the industry by granting funds for performing research and development activities. Stanford healthcare uses genomic information to develop a personalized treatment for patients suffering from chronic illness.

The lower costs of genetic procedures is likely to contribute to the development of the genomic market in the forthcoming years. Technological advancements in genomic medicine which include Next-generation Sequencing (NGS), Sanger sequencing, Polymerase Chain Reactions (PCR), and microarray are likely to drive the market. Of these, Polymerase Chain Reactions (PCR) covered the maximum share in the global market in 2018. The easy availability and extensive use of this technology are responsible for this segment’s growth. Owing to the increasing number of genetic studies, the demand for genomics is expected to fuel in healthcare facilities & diagnostic centers, Contract Research Organization (CROs) and others.

Secondary Data Sources That We Refer To

  • Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market
  • Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.
  • Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics
  • Industry journals and paid databases

More Trending Topics From Fortune Business [email protected]

Defibrillator Market Size Growth & Industry Dynamics 2026

Diabetes Treatment Devices Market Size, Share & Growth Report 2026

Intravenous Immunoglobulin Market Size, Share | Growth Report, 2025

About us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Fortune Business Insights™
Linkedin | Twitter | Blogs

Categories
Press Release

Genomics Market Expanding with Technological Drive of Pharmaceutical Companies

The use of genomics is expanding in the medical industry, which is creating growth opportunities for the Global Genomics Market. Fortune Business Insights in a new report, titled “Genomics: Global Market Analysis, Insights and Forecast, 2019-2026” offers valuable insights into the factors enabling growth in the market.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Veritas Genetics Launched myGenome to Offer Personalized Services to its Customers

General Electric Company, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Agilent Technologies, Inc., IntegraGen, QIAGEN, BGI, F. Hoffmann-La Roche Ltd, Danaher, and Illumina, Inc. are some of the leading players in the global genomics market. Among these, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., and Illumina, Inc. are projected to dominate the global market. Strong geographical presence and robust portfolio are factors responsible for their prominent position in the market. Several companies are entering into strategic alliances to better their market position and increase revenue.

Bristol Myers Squibb collaborated with Foundation Medicine in March 2017. This collaboration will help the former company to leverage the latter’s molecular information and genomic profiling solutions. Furthermore, it will help Bristol Myers to identify biomarkers such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB) in cancer patients. Another company called 10X Genomics acquired an epigenomics-based startup called Epinomics in August 2018. This acquisition will help the company strengthen its market position.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941

Some major points from Table of Content: 

  1. Introduction

1.1.ResearchScope

1.2.MarketSegmentation

1.3.ResearchMethodology

1.4.Definitionsand Assumptions

2.Executive Summary

3.Market Dynamics

3.1.MarketDrivers

3.2.MarketRestraints

3.3.MarketOpportunities

3.4 MarketTrends

4.Key Insights

4.1GenomicsResearch Spending – For Key Countries, 2018

4.2RegulatoryScenario – For Key Countries

4.3Overview ofGenomics Service Provider

4.4New ProductLaunch

4.5Start-upswith their Funding Overview

4.5Key IndustryDevelopments – Mergers, Acquisitions and Partnerships

5.Global Genomics Market Analysis,Insights and Forecast, 2015-2026

5.1.KeyFindings / Summary

5.2.MarketAnalysis, Insights and Forecast – By Type

5.2.1Product

5.2.1.1Instruments& Software

5.2.1.2Consumables

5.2.2Services

5.3.MarketAnalysis, Insights and Forecast – By Technology

5.3.1PolymeraseChain Reaction (PCR)

5.3.2Next-generationSequencing (NGS)

5.3.3Microarray

5.3.4SangerSequencing

5.3.5Others

5.4.MarketAnalysis, Insights and Forecast – By Application

5.4.1Diagnostics

5.4.2Research

5.4.3Others

5.5.MarketAnalysis, Insights and Forecast – By End User

5.5.1ResearchInstitutes

5.5.2HealthcareFacilities & Diagnostic Centers

5.5.3Pharmaceutical& Biotechnological Companies

5.5.4ContractResearch Organization (CROs)

5.6.MarketAnalysis, Insights and Forecast – By Region

5.6.1NorthAmerica

5.6.2Europe

5.6.3AsiaPacific

5.6.4LatinAmerica

5.6.5MiddleEast & Africa

More Trending Topics From Fortune Business [email protected]

Diabetes Monitoring Devices Market: 2019 Worldwide Opportunities, Key Players, Market Share and Competitive Landscape

Dental Implants Market Global Key Leaders Analysis, Segmentation, Growth, Future Trends Forecast till 2026 

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Categories
Press Release

Genomics Market Is Expected to Grasp US$ 62,614.6 Mn by 2026, at a CAGR Of 18.7%

Genomics Market is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, The Global Genomics Market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026. In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026.

Segmentation

By Product Type

  • Reagents
  • Kits
  • Enzymes
  • Others

By Technology

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • MicroRNA Modification
  • Large Non-coding RNA
  • Chromatin Structures
  • Others

By Application

  • Pharmaceutical
  • Diagnostics

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941

Veritas Genetics Launched myGenome to Offer Personalized Services to its Customers

General Electric Company, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Agilent Technologies, Inc., IntegraGen, QIAGEN, BGI, F. Hoffmann-La Roche Ltd, Danaher, and Illumina, Inc. are some of the leading players in the global genomics market. Among these, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., and Illumina, Inc. are projected to dominate the global market. Strong geographical presence and robust portfolio are factors responsible for their prominent position in the market. Several companies are entering into strategic alliances to better their market position and increase revenue. Bristol Myers Squibb collaborated with Foundation Medicine in March 2017. This collaboration will help the former company to leverage the latter’s molecular information and genomic profiling solutions. Furthermore, it will help Bristol Myers to identify biomarkers such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB) in cancer patients. Another company called 10X Genomics acquired an epigenomics-based startup called Epinomics in August 2018. This acquisition will help the company strengthen its market position.

Some major points from Table of Content:

  1. Introduction

1.1.ResearchScope

1.2.MarketSegmentation

1.3.ResearchMethodology

1.4.Definitionsand Assumptions

2.Executive Summary

3.Market Dynamics

3.1.MarketDrivers

3.2.MarketRestraints

3.3.MarketOpportunities

3.4 MarketTrends

4.Key Insights

4.1GenomicsResearch Spending – For Key Countries, 2018

4.2RegulatoryScenario – For Key Countries

4.3Overview ofGenomics Service Provider

4.4New ProductLaunch

4.5Start-upswith their Funding Overview

4.5Key IndustryDevelopments – Mergers, Acquisitions and Partnerships

5.Global Genomics Market Analysis,Insights and Forecast, 2015-2026

5.1.KeyFindings / Summary

5.2.MarketAnalysis, Insights and Forecast – By Type

5.2.1Product

5.2.1.1Instruments& Software

5.2.1.2Consumables

5.2.2Services

5.3.MarketAnalysis, Insights and Forecast – By Technology

5.3.1PolymeraseChain Reaction (PCR)

5.3.2Next-generationSequencing (NGS)

5.3.3Microarray

5.3.4SangerSequencing

5.3.5Others

5.4.MarketAnalysis, Insights and Forecast – By Application

5.4.1Diagnostics

5.4.2Research

5.4.3Others

5.5.MarketAnalysis, Insights and Forecast – By End User

5.5.1ResearchInstitutes

5.5.2HealthcareFacilities & Diagnostic Centers

5.5.3Pharmaceutical& Biotechnological Companies

5.5.4ContractResearch Organization (CROs)

5.6.MarketAnalysis, Insights and Forecast – By Region

5.6.1NorthAmerica

5.6.2Europe

5.6.3AsiaPacific

5.6.4LatinAmerica

5.6.5MiddleEast & Africa

More Trending Topics From Fortune Business [email protected]

Diabetes Monitoring Devices Market to Expand at 5.4% CAGR by 2026, F. Hoffmann-La Roche Ltd.’s Robust Distribution Network Strengthens its Market Position: Fortune Business Insights

Intravenous Immunoglobulins Market to Reach US$ 15,789.1 Mn by 2025, Exhibiting A CAGR of 6.2% | Fortune Business Insights

Categories
Press Release

Global US$ 62,614.6 Mn Genomics Market Forecast to 2026 – Entry of New Players and Start-Ups in the Genomics Field are Driving the Growth of the Market

The use of genomics is expanding in the medical industry, which is creating growth opportunities for the Global Genomics Market. Fortune Business Insights in a new report, titled Genomics: Global Market Analysis, Insights and Forecast, 2019-2026 offers valuable insights into the factors enabling growth in the market.

Genomics Market is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, The Global Genomics Market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026. In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026.

Segmentation

By Product Type

  • Reagents
  • Kits
  • Enzymes
  • Others

By Technology

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • MicroRNA Modification
  • Large Non-coding RNA
  • Chromatin Structures
  • Others

By Application

  • Pharmaceutical
  • Diagnostics

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Get [email protected] https://www.fortunebusinessinsights.com/enquiry/check-discount/genomics-market-100941

Adoption of Advanced Technologies Renders North America Dominant

From a geographical standpoint, North America dominated the global genomics market in 2018. The region will continue to maintain its dominance through the forecast period. Rapid technological advancements and the presence of sophisticated healthcare infrastructure are driving the market in this region. In 2018, North America was valued at US$ 6,959.3 Mn. The demand for genomic medicine is increasing in North America on account of the rising adoption of personalized medicine and new sequencing technologies.

Europe is expected to display great growth potential owing to the wide availability of funds and the presence of large MNCs. Governments in the U.K. is increasingly making investments in research and development (R&D) activities to favour the expansion of the market in Europe.

The market in Asia Pacific is likely to witness strong growth during the forecast years. The primary factor responsible for the growth is developing healthcare infrastructure. The awareness about genomic technologies is increasing in countries such as India and China, as people in these countries are becoming more aware with regards to the detection of genetic disorders, their treatment and prognosis. All these factors are enabling growth in the market.

Some major points from Table of Content:

  1. Introduction

1.1.ResearchScope

1.2.MarketSegmentation

1.3.ResearchMethodology

1.4.Definitionsand Assumptions

2.Executive Summary

3.Market Dynamics

3.1.MarketDrivers

3.2.MarketRestraints

3.3.MarketOpportunities

3.4 MarketTrends

4.Key Insights

4.1GenomicsResearch Spending – For Key Countries, 2018

4.2RegulatoryScenario – For Key Countries

4.3Overview ofGenomics Service Provider

4.4New ProductLaunch

4.5Start-upswith their Funding Overview

4.5Key IndustryDevelopments – Mergers, Acquisitions and Partnerships

5.Global Genomics Market Analysis,Insights and Forecast, 2015-2026

5.1.KeyFindings / Summary

5.2.MarketAnalysis, Insights and Forecast – By Type

5.2.1Product

5.2.1.1Instruments& Software

5.2.1.2Consumables

5.2.2Services

5.3.MarketAnalysis, Insights and Forecast – By Technology

5.3.1PolymeraseChain Reaction (PCR)

5.3.2Next-generationSequencing (NGS)

5.3.3Microarray

5.3.4SangerSequencing

5.3.5Others

5.4.MarketAnalysis, Insights and Forecast – By Application

5.4.1Diagnostics

5.4.2Research

5.4.3Others

5.5.MarketAnalysis, Insights and Forecast – By End User

5.5.1ResearchInstitutes

5.5.2HealthcareFacilities & Diagnostic Centers

5.5.3Pharmaceutical& Biotechnological Companies

5.5.4ContractResearch Organization (CROs)

5.6.MarketAnalysis, Insights and Forecast – By Region

5.6.1NorthAmerica

5.6.2Europe

5.6.3AsiaPacific

5.6.4LatinAmerica

5.6.5MiddleEast & Africa

Categories
Press Release

Genomics Market Expanding with Technological Drive of Pharmaceutical Companies

The use of genomics is expanding in the medical industry, which is creating growth opportunities for the Global Genomics Market. Fortune Business Insights in a new report, titled Genomics: Global Market Analysis, Insights and Forecast, 2019-2026 offers valuable insights into the factors enabling growth in the market.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941

Key players leading the Global Genomics Market include

  • Thermo Fisher Scientific Inc.,
  • Oxford Nanopore Technologies,
  • Agilent Technologies, Inc.,
  • IntegraGen,
  • QIAGEN,
  • BGI
  • Danaher,
  • Illumina, Inc.,
  • Hoffmann-La Roche Ltd,
  • include Next-generation Sequencing (NGS),
  • Sanger sequencing,
  • Polymerase Chain Reactions (PCR)

The gradual shift from traditional medicine to precision medicine is positively changing the healthcare environment. Genomics plays a crucial role in the treatment and diagnosis of chronic diseases.

Browse Complete Report [email protected] https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Genomics Market is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, The Global Genomics Market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026. In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026.

Adoption of Advanced Technologies Renders North America Dominant

From a geographical standpoint, North America dominated the global genomics market in 2018. The region will continue to maintain its dominance through the forecast period. Rapid technological advancements and the presence of sophisticated healthcare infrastructure are driving the market in this region. In 2018, North America was valued at US$ 6,959.3 Mn. The demand for genomic medicine is increasing in North America on account of the rising adoption of personalized medicine and new sequencing technologies.

Europe is expected to display great growth potential owing to the wide availability of funds and the presence of large MNCs. Governments in the U.K. is increasingly making investments in research and development (R&D) activities to favour the expansion of the market in Europe.

Order Complete [email protected] https://www.fortunebusinessinsights.com/checkout-page/100941

A Myriad of R&D Activities Has Spurred Growth Prospects for Genomics Market

“Several services and start-up companies are paving their way into genomics industry by offering services which include ancestry services, direct-to-customer genomic services, among others,” stated a lead analyst at Fortune Business Insights. “Rising support from governments regarding research and funding is expected to contribute to the growth of the market,” he added. Several genomic institutes are supporting the industry by granting funds for performing research and development activities. Stanford healthcare uses genomic information to develop a personalized treatment for patients suffering from chronic illness.

Segmentation

By Product Type

  • Reagents
  • Kits
  • Enzymes
  • Others

By Technology

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • MicroRNA Modification
  • Large Non-coding RNA
  • Chromatin Structures
  • Others

By Application

  • Pharmaceutical
  • Diagnostics

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

More Trending Topics From Fortune Business [email protected]

Biopesticides Market to reach US$ 10.19 Billion by 2025, at a CAGR of 14.93% | Exclusive Report by Fortune Business Insights

Crop Protection Chemicals Market to Reach US$ 68.82 Bn by 2025, Relaxation in Usage Guidelines to Boost the Market, says Fortune Business Insights

Categories
Press Release

Global Genomics Market Trends, Demand, Growth Opportunity, Regional Outlook, & Forecast 2018-2026

Genomics Market is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, The Global Genomics Market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026. In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026.

Adoption of Advanced Technologies Renders North America Dominant

From a geographical standpoint, North America dominated the global genomics market in 2018. The region will continue to maintain its dominance through the forecast period. Rapid technological advancements and the presence of sophisticated healthcare infrastructure are driving the market in this region. In 2018, North America was valued at US$ 6,959.3 Mn. The demand for genomic medicine is increasing in North America on account of the rising adoption of personalized medicine and new sequencing technologies.

Segmentation

By Product Type

  • Reagents
  • Kits
  • Enzymes
  • Others

By Technology

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • MicroRNA Modification
  • Large Non-coding RNA
  • Chromatin Structures
  • Others

By Application

  • Pharmaceutical
  • Diagnostics

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941

Veritas Genetics Launched myGenome to Offer Personalized Services to its Customers

General Electric Company, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Agilent Technologies, Inc., IntegraGen, QIAGEN, BGI, F. Hoffmann-La Roche Ltd, Danaher, and Illumina, Inc. are some of the leading players in the global genomics market. Among these, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., and Illumina, Inc. are projected to dominate the global market. Strong geographical presence and robust portfolio are factors responsible for their prominent position in the market.

A Myriad of R&D Activities Has Spurred Growth Prospects for Genomics Market

“Several services and start-up companies are paving their way into genomics industry by offering services which include ancestry services, direct-to-customer genomic services, among others,” stated a lead analyst at Fortune Business Insights. “Rising support from governments regarding research and funding is expected to contribute to the growth of the market,” he added. Several genomic institutes are supporting the industry by granting funds for performing research and development activities. Stanford healthcare uses genomic information to develop a personalized treatment for patients suffering from chronic illness.

Secondary Data Sources That We Refer To

  • Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market
  • Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.
  • Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics
  • Industry journals and paid databases

Its All About Building Intelligent Machines to Simplify Complex Tasks: Introducing Surgical Robots

The lower costs of genetic procedures is likely to contribute to the development of the genomic market in the forthcoming years. Technological advancements in genomic medicine which include Next-generation Sequencing (NGS), Sanger sequencing, Polymerase Chain Reactions (PCR), and microarray are likely to drive the market. Of these, Polymerase Chain Reactions (PCR) covered the maximum share in the global market in 2018. The easy availability and extensive use of this technology are responsible for this segment’s growth. Owing to the increasing number of genetic studies, the demand for genomics is expected to fuel in healthcare facilities & diagnostic centers, Contract Research Organization (CROs) and others.

More Trending Topics From Fortune Business [email protected]

Biopesticides Market to reach US$ 10.19 Billion by 2025, at a CAGR of 14.93% | Exclusive Report by Fortune Business Insights

Crop Protection Chemicals Market to Reach US$ 68.82 Bn by 2025, Relaxation in Usage Guidelines to Boost the Market, says Fortune Business Insights